* Laboratory Corporation of America Holdings LH.N LH is
expected to show a fall in quarterly revenue when it reports
results on February 16.
* The Burlington North Carolina-based company is expected
to
report a 7.7% decrease in revenue to $3.745 billion from $4.06
billion a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Laboratory
Corporation of
America Holdings is for earnings of $4.11 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Laboratory
Corporation of America Holdings is $285, above its last
closing price of $248.13.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 4.67 4.67 4.68 Beat 0.3
Jun. 30 2022 4.73 4.70 4.95 Beat 5.3
Mar. 31 2022 6.07 5.98 6.11 Beat 2.2
Dec. 31 2021 6.27 5.80 6.77 Beat 16.8
Sep. 5.17 4.92 6.82 Beat 38.7
30 2021
Jun. 30 2021 5.56 5.53 6.13 Beat 10.9
Mar. 31 2021 7.47 7.43 8.79 Beat 18.3
Dec. 31 2020 8.39 8.11 10.56 Beat 30.2
This summary was machine generated February 14 at 15:31 GMT.
All figures in US dollars unless otherwise stated